newsfilter
← Latest News
GlobeNewswire·

Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference

SAN FRANCISCO and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (NASDAQ:APGE), today announced that members of management will participate in a fireside chat at the Guggenheim SMID Cap Biotech